Year: 1998
Type: review
Abstract: GLUCOCORTICOIDS are potent inhibitors of inflammatory processes and are widely used in the treatment of asthma. The anti-inflammatory effects are mediated either by direct binding of the glucocorticoid/glucocorticoid receptor complex to glucocorticoid responsive elements in the promoter region of genes, or by an interaction of this complex with other transcription factors, in particular activating protein-1 or nuclear factor-kappaB. Glucocorticoids inhibit many inflammation-associated molecules such as cytokines, chemokines, arachidonic acid metabolites, and adhesion molecules. In contrast, anti-inflammatory mediators often are up-regulated by glucocorticoids. In vivo studies have shown that treatment of asthmatic patients with inhaled glucocorticoids inhibits the bronchial inflammation and simultaneously improves their lung function. In this review, our current knowledge of the mechanism of action of glucocorticoids and their anti-inflammatory potential in asthma is described. Since bronchial epithelial cells may be important targets for glucocorticoid therapy in asthma, the effects of glucocorticoids on epithelial expressed inflammatory genes will be emphasized.
Source: Mediators of Inflammation
Author: V. H. J. van der Velden
Institution: Erasmus University Rotterdam
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Keywords: glucocorticoids, asthma, anti-inflammatory mechanism, glucocorticoid receptor, transcriptional regulation, glucocorticoid response element, AP-1, NF-κB, cytokines, chemokines, arachidonic acid metabolites, adhesion molecules, inhaled corticosteroids, bronchial inflammation, lung function, bronchial epithelial cells, inflammatory gene expression
Open Access status: gold
Estimated APC paid: $3,040
OpenAlex ID: W1982286823
